NCT07156201
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 28, 2025
Completion: Mar 31, 2026